MktsMarkets

HeartSciences Inc.
NASDAQ: HSCSKey statistics
HSCS News
Stories mentioning HSCS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Jan 31 | Q4 '25Oct 31 | Q3 '25Jul 31 | Q2 '25Apr 30 | Q1 '25Jan 31 | Q4 '24Oct 31 | Q3 '24Jul 31 | Q2 '24Apr 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 2.00 | 2.00 | 0.00 | ||||
| Cost of Goods Sold | 0.00 | 1.00 | 1.00 | 0.00 | ||||
| Gross Profit | 0.00 | 1.00 | 1.00 | 2.00 | 0.00 | 0.00 | 0.00 | 1.00 |
| Operating Expenses | ||||||||
| Research & Development | 639.00 | 727.00 | 997.00 | 929.00 | 1,033 | 1,199 | 1,225 | 1,046 |
| Sales General & Admin | 1,290 | 1,348 | 878.00 | 994.00 | 1,338 | 786.00 | 851.00 | 834.00 |
| Total Operating Expenses | 1,929 | 2,075 | 1,875 | 1,923 | 2,371 | 1,985 | 2,076 | 1,879 |
| Operating Income (Loss) | (1,929) | (2,073) | (1,874) | (1,921) | (2,371) | (1,985) | (2,076) | (1,880) |
| Interest Income | ||||||||
| Interest Expense | 22.00 | |||||||
| Other Expense | 5.00 | 15.00 | ||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (1,985) | (2,351) | (2,055) | (2,094) | (2,536) | (2,083) | (2,052) | (1,846) |
| Earnings Per Share (Basic) | (0.63) | (0.85) | (1.58) | (2.23) | (2.57) | (2.27) | (2.64) | (5.23) |
| Earnings Per Share (Diluted) | (0.85) | (1.58) | (2.23) | (2.57) | (2.27) | (2.64) | (5.23) | |
| Weighted Average Shares Outstanding (Basic) | 3,162 | 2,780 | 1,304 | 938.00 | 986.00 | 917.00 | 778.00 | 353.00 |
| Weighted Average Shares Outstanding (Diluted) | 2,780 | 1,304 | 938.00 | 986.00 | 917.00 | 778.00 | 353.00 | |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About HSCS
HeartSciences Inc. (NASDAQ: HSCS) is a stock listed on the Nasdaq Stock Market under the ticker symbol HSCS. It last traded at $2.71 (Nov 9, 2026, 4:00 PM ET), down 4.2% on the day. That gives HeartSciences a market capitalisation of $13.5M.
Over the past 52 weeks HSCS has traded between $1.63 and $5.25.
Revenue for the quarter ended Jan 31, 2026 was $0; a net loss of $2.0M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Jan 31, 2026 | $0 | -$2.0M | — |
| Oct 31, 2025 | $2.0K | -$2.4M | -117550.0% |
| Jul 31, 2025 | $2.0K | -$2.1M | -102750.0% |
| Apr 30, 2025 | — | -$2.1M | — |
From HeartSciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…